Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Milrinone Versus Dobutamine in a Heterogeneous Population of Critically Ill Patients

NCT03207165 is registered in ClinicalTrials.gov with Ottawa Heart Institute Research Corporation as lead sponsor.

NCT NCT03207165
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03207165 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Milrinone Versus Dobutamine in a Heterogeneous Population of Critically Ill Patients
Lead sponsor
Ottawa Heart Institute Research Corporation
Phase
Phase 4
Overall status
Completed
Start date
August 30, 2017
Completion date
June 12, 2020
Enrollment
192 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome, cardiogenic shock, low cardiac output syndrome, pulmonary edema